Sirio Pharma

Established in 1993, Sirio Pharma Co, Ltd (SIRIO) is a leading global nutraceutical contract development and manufacturing organization (CDMO) with extensive expertise in an array of delivery formats, including gummies, softgels, capsules, tablets, powders, functional beverages, probiotics, and other innovative dosage forms. Dedicated to excellence in product development and manufacturing. SIRIO operates multiple state-of-the-art manufacturing sites across the United States, Germany and China. In 2023, SIRIO acquired Best Formulations, further solidifying its position as a premier global nutraceutical CDMO, and significantly enhancing its manufacturing capabilities and capacity – with a notable focus on bolstering its presence in North America.